Peoria, IL 的 心臟衰竭 臨床試驗
8 項針對 心臟衰竭 的研究正在 Peoria（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
招募中3 期
- Research Site, Peoria
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
招募中3 期
- CON-10019, Peoria, IL, Peoria
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
招募中3 期
- Peoria, IL Investigative Site 10019, Peoria
- Peoria, IL Investigative Site 10010, Peoria
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
招募中2 期
- Local Institution - 153, Peoria
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
招募中2 期
- Methodist Medical Center of Illinois, Peoria
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
招募中3 期
- Tenax Investigational Site, Peoria
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
招募中3 期
- Methodist Medical Center of Illinois, Peoria
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
招募中3 期
- FIN-10019, Peoria, IL, Peoria
其他城市的 心臟衰竭 試驗
- New York City, NY51 項研究
- Boston, MA44 項研究
- Dallas, TX42 項研究
- Houston, TX36 項研究
- Cleveland, OH33 項研究
- Chicago, IL31 項研究
- Philadelphia, PA31 項研究
- San Francisco, CA29 項研究
- St. Louis, MO26 項研究
- Durham, NC26 項研究
- Kansas City, MO25 項研究
- Atlanta, GA25 項研究
Peoria 的其他研究
- 非小細胞肺癌21 項研究
- 肺癌12 項研究
- 大腸直腸癌12 項研究
- 前列腺癌9 項研究
- 乳癌8 項研究
- 卵巢癌7 項研究
- 頭頸部鱗狀細胞癌7 項研究
- 轉移性癌症7 項研究
- 胰臟癌7 項研究
- 癌症（所有類型）7 項研究
- 黑色素瘤6 項研究
- 子宮內膜癌6 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。